Black Rock Inc. Matinas Bio Pharma Holdings, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Matinas Bio Pharma Holdings, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,482,400 shares of MTNB stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,482,400

Previous 2,482,400 -0.0%

Holding current value

$1.29 Million

Previous $670,000 40.75%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.19 - $0.3 $3,536 - $5,583	-18,611 Reduced 0.74%	2,482,400 $670,000
Q4 2023 Feb 13, 2024	SELL	$0.12 - $0.64 $29 - $155	-243 Reduced 0.01%	2,501,011 $550,000
Q3 2023 Nov 13, 2023	SELL	$0.12 - $0.41 $773 - $2,642	-6,445 Reduced 0.26%	2,501,254 $325,000
Q2 2023 Aug 11, 2023	BUY	$0.35 - $0.72 $13,909 - $28,614	39,742 Added 1.61%	2,507,699 $902,000
Q1 2023 May 12, 2023	SELL	$0.39 - $0.6 $96,791 - $148,909	-248,183 Reduced 9.14%	2,467,957 $1.16 Million
Q4 2022 Feb 13, 2023	SELL	$0.46 - $42.69 $718,969 - $66.7 Million	-1,562,978 Reduced 36.53%	2,716,140 $1.36 Million
Q3 2022 Nov 14, 2022	SELL	$0.63 - $33.0 $41,478 - $2.17 Million	-65,839 Reduced 1.52%	4,279,118 $2.72 Million
Q2 2022 Aug 12, 2022	BUY	$0.63 - $0.96 $12,539 - $19,107	19,904 Added 0.46%	4,344,957 $3.43 Million
Q1 2022 May 12, 2022	BUY	$0.5 - $1.06 $14,821 - $31,421	29,643 Added 0.69%	4,325,053 $3.48 Million
Q4 2021 Feb 10, 2022	BUY	$0.92 - $1.22 $1.45 Million - $1.92 Million	1,571,635 Added 57.7%	4,295,410 $4.34 Million
Q3 2021 Nov 09, 2021	BUY	$0.67 - $1.51 $14,916 - $33,618	22,264 Added 0.82%	2,723,775 $3.54 Million
Q2 2021 Aug 11, 2021	BUY	$0.75 - $1.1 $2.03 Million - $2.97 Million	2,701,511 New	2,701,511 $2.09 Million

Others Institutions Holding MTNB

# of Institutions

Shares Held

3.52M

Call Options Held

Put Options Held

View Full List

About Matinas BioPharma Holdings, Inc.

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $113M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

More about MTNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account